Azintuxizumab vedotin Uses, Dosage, Side Effects and more
Azintuxizumab vedotin is under investigation in clinical trial NCT02951117 (A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment).
| Attribute | Details |
|---|---|
| Trade Name | Azintuxizumab vedotin |
| Generic | Azintuxizumab vedotin |
| Azintuxizumab vedotin Other Names | Azintuxizumab vedotin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
